Skip to main content
. Author manuscript; available in PMC: 2019 Apr 20.
Published in final edited form as: Arthritis Care Res (Hoboken). 2018 Feb 22;70(4):643–647. doi: 10.1002/acr.23320

Table 1.

Distribution of current and cumulative prednisone-equivalent glucocorticoid (GC) dosage in patients with polymyalgia rheumatica

Starting dose 1 year 2 years 5 years 10 years
Current dose, mg/day*          
 No. 352 229 130 57 16
 Mean ± SD 16.9 ± 7.1 5.9 ± 5.6 6.1 ± 7.6 7.2 ± 9.5 9.1 ± 14.1
 Median 15.0 5.0 4.4 5.0 5.0
 Quartile 1, quartile 3 15.0, 20.0 2.8, 7.6 2.5, 7.0 3.0, 6.8 3.0, 9.1
 Range 5.0–60.0 1.0–60.0 1.0–60.0 1.0–60.0 1.0–60.0
Cumulative dose, grams          
 No. 359 334 302 201 78
 Mean ± SD 0.0 ± 0.0 2.9 ± 1.8 4.0 ± 3.5 6.3 ± 9.8 9.4 ± 25.1
 Median 0.0 2.7 3.4 3.9 4.2
 Quartile 1, quartile 3 0.0, 0.0 1.9, 3.6 2.1, 5.4 2.1, 7.9 1.9, 8.4
 Range 0.0–0.1 0.0–21.8 0.0–43.7 0.0–109.4 0.0–218.9
*

Among patients on GC at each time point.

Among all patients being followed, still under observation at each time point, including patients who are no longer on glucocorticoid therapy.